Fexofenadine | List of Frontiers open access articles

Original Research

Published on 13 Nov 2025

Changed expression of placental transporters and disrupted epigenetic patterns in a rat model of schizophrenia

in Drug Metabolism and Transport

Péter Szatmári
Adrienn Seres-Bokor
Anita Sztojkov-Ivanov
Gabriella Kékesi
Gyöngyi Horváth
Eszter Ducza

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1673124

1,383 views

Original Research

Published on 14 Feb 2020

Limited Sampling Modeling for Estimation of Phenotypic Metrics for CYP Enzymes and the ABCB1 Transporter Using a Cocktail Approach

in Drug Metabolism and Transport

Eduardo Barbosa Coelho
Diego Alberto Ciscato Cusinato
João Paulo Ximenez
Vera Lucia Lanchote
Claudio José Struchiner
Guilherme Suarez-Kurtz

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00022

3,470 views
10 citations

Original Research

Published on 24 Aug 2021

Fexofenadine Protects Against Intervertebral Disc Degeneration Through TNF Signaling

in Cellular Biochemistry

Kaiwen Liu
Jianlu Wei
Guohua Li
Ronghan Liu
Dawang Zhao
Yuanqiang Zhang
Jie Shi
Qing Xie
Lei Cheng

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2021.687024

9,936 views
26 citations

Original Research

Published on 17 Jul 2023

Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation

in General Cardiovascular Medicine

Fabrizio Salvucci
Roberto Codella
Adriana Coppola
Irene Zacchei
Gabriella Grassi
Maria Luisa Anti
Nicolita Nitisoara
Livio Luzi
Carmine Gazzaruso

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1202696

64,854 views
22 citations

Original Research

Published on 25 Nov 2022

Gut microbiome and fecal metabolic alteration in systemic lupus erythematosus patients with depression

in Intestinal Microbiome

Han Yao
Hao Yang
Yueying Wang
Qian Xing
Lin Yan
Yaru Chai

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.1040211

6,328 views
21 citations

Original Research

Published on 12 Jun 2024

Establishment of a human nasal epithelium model of histamine-induced inflammation to assess the activity of fexofenadine as an inverse agonist and its link to clinical benefit

in Inflammation Pharmacology

Anne Barbot
Michele Lheritier-Barrand
Margarita Murrieta-Aguttes
Maud Leonetti
Jimmy Vernaz
Song Huang
Samuel Constant
Bernadett Boda

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393702

3,181 views
1 citation

Articles

Changed expression of placental transporters and disrupted epigenetic patterns in a rat model of schizophrenia

Limited Sampling Modeling for Estimation of Phenotypic Metrics for CYP Enzymes and the ABCB1 Transporter Using a Cocktail Approach

Fexofenadine Protects Against Intervertebral Disc Degeneration Through TNF Signaling

Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation

Gut microbiome and fecal metabolic alteration in systemic lupus erythematosus patients with depression

Establishment of a human nasal epithelium model of histamine-induced inflammation to assess the activity of fexofenadine as an inverse agonist and its link to clinical benefit